Muhammad Wasif Saif1. Show Affiliations » 1. Section of GI Cancers and Experimental Therapeutics, Tufts University School of Medicine, 800 Washington Street, Boston, MA 02111, USA.
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma/blood supplyAdenocarcinoma/drug therapyAntineoplastic Agents/therapeutic useCisplatin/therapeutic useDeoxycytidine/analogs & derivativesDeoxycytidine/therapeutic useDrug Therapy, CombinationHumansNeovascularization, Pathologic/drug therapyNiacinamide/analogs & derivativesNiacinamide/therapeutic usePancreatic Neoplasms/blood supplyPancreatic Neoplasms/drug therapyPhenylurea Compounds/therapeutic useSorafenibTreatment Outcome
Substances： See more » Antineoplastic AgentsPhenylurea CompoundsDeoxycytidineNiacinamideSorafenibgemcitabineCisplatin
Year: 2013 PMID： 24322903 DOI： 10.1038/nrgastro.2013.234
Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802